Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?

Figure 4

(a) Crude, unadjusted post-TACE survival as a function of mRECIST category. (b) Adjusted post-TACE survival as a function of mRECIST category.

(a)

(b)